Abhay P. S. Rathore

Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin

Moon Y. F. Tay, Johanna E. Fraser, Wing Ki Chan et al. · Antiviral Research · 2013 · 320 citations

Virus Structure, Dengue Virus, Molecular Virology +7

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

Jenny G. Low, Cynthia Sung, Limin Wijaya et al. · The Lancet Infectious Diseases · 2014 · 240 citations

Phase 1B, Proof-of-concept Trial, Clinical Trials +5

Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance

Ashley L. St. John, Abhay P. S. Rathore, Han Yap et al. · Proceedings of the National Academy of Sciences · 2011 · 218 citations

Innate Immune System, Immunology, Immune Regulation +21

Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage

Ashley L. St. John, Abhay P. S. Rathore, Raghavan Bhuvanakantham et al. · eLife · 2013 · 185 citations · Full text

Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model

Abhay P. S. Rathore, Prasad N. Paradkar, Satoru Watanabe et al. · Antiviral Research · 2011 · 158 citations

Celgosivir Treatment Misfolds, Medicine, Pathogenesis +8